KCG
HAE icon

Knight Capital Group’s Haemonetics HAE Stock Holding History

Knight Capital Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$231K Buy
+5,591
New +$226K ﹤0.01% 2558

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Knight Capital Group's HAE Position: Q2 2013 in Review

Knight Capital Group opened a new position in Haemonetics (HAE) in Q2 2013: 5,591 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #2558 among its holdings.

195 funds tracked by Wall St. Rank hold HAE as of Q2 2013.

  • Knight Capital Group held 5,591 shares of Haemonetics worth $231K as of Q2 2013.
  • Haemonetics was a new Knight Capital Group position in Q2 2013.
  • Haemonetics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2558 holding.
  • 195 funds tracked by Wall St. Rank held Haemonetics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.